Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-01-02 @ 12:51 PM
Study NCT ID:
NCT00914758
Status:
UNKNOWN
Last Update Posted:
2009-06-05
First Post:
2009-06-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)
Sponsor:
Washington Neuropsychology Research Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
WNRG02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Jeffrey Wilken, Ph.D./Executive Director
Old Organization:
Washington Neuropsychology Research Group
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |